Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"Multinational pharmaceutical companies"”.

  1. An investigation of alliances between western life-science therapeutic and Indian firms

    Large pharmaceutical companies (Multinational Pharmaceutical Companies or MPCs) have struggled in recent years with the rapidly accelerating costs of drug-discovery research and development. These costs continue to rise while resulting in fewer drug leads. Several industries have realized …

    mit Repository record for An investigation of alliances between western life-science therapeutic and Indian firms (opens in a new tab)

  2. The Quality of Work Life: An Empirical Study

    … the quality of work life in a selection of pharmaceutical companies in Egypt. It aims to test the relationships between the employees' perceptions of their quality of work life and; their perceptions of the degree of participation in decisionmaking available to them, their perceptions of …

    plymouth Repository record for The Quality of Work Life: An Empirical Study (opens in a new tab)

  3. An investigation into the issues influencing the adoption of e-business within the Portuguese subsidiaries of the pharmaceutical industry

    … adopt e-business at different rates. Why do some companies actively adopt e-business while others take a more cautious attitude? The pharmaceutical industry provides a rich platform for the exploitation of e-business as a means of improving the reply and reducing the costs of the business process …

    de-montfort Repository record for An investigation into the issues influencing the adoption of e-business within the Portuguese subsidiaries of the pharmaceutical industry (opens in a new tab)

  4. Expanding Access to Novel Antibacterial Therapeutics in Low- and Middle-Income Countries: Leveraging Donor-Funded Pooled Procurement

    … 2022). Because of limited returns on investment, multinational pharmaceutical companies have largely abandoned antibacterial development. This void has been filled by smaller product developers vastly located in the United States and Europe who have limited resources and experience in seeking …

    iupui Repository record for Expanding Access to Novel Antibacterial Therapeutics in Low- and Middle-Income Countries: Leveraging Donor-Funded Pooled Procurement (opens in a new tab)